ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Single-Cell Transcriptomics Unravels Growth Factor Erv1-Like Mediated Ferroptosis as a Key Driver of Intestinal Epithelial Dysfunction in Ulcerative Colitis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mechanistic Networks, Cellular Specificity, and Therapeutic Opportunities of Ferroptosis in Ulcerative Colitis.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Identification of ATF3 as a Potential Key Biomarker for Hypertensive Nephropathy via Single-Cell Transcriptome Sequencing.Inflammation · 2026Article
- Epithelial cell-based multi-omics integration identifies SPINK5 and SRI as novel diagnostic biomarkers for ulcerative colitis.Frontiers in pharmacology · 2026Article
- Single-Cell Transcriptomics Unravels Growth Factor Erv1-Like Mediated Ferroptosis as a Key Driver of Intestinal Epithelial Dysfunction in Ulcerative Colitis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Inflammatory bowel disease (IBD) is a group of chronic, relapsing, and idiopathic inflammatory disorders of the gastrointestinal tract, primarily including ulcerative colitis (UC) and Crohn's disease (CD). The pathogenesis of UC remains incompletely understood, particularly regarding epithelial iron homeostasis and the regulation of cell death. In recent years, the application of single-cell RNA sequencing (scRNA-seq) has provided a powerful tool for dissecting cell-type-specific molecular mechanisms in UC. In this study, a comprehensive analysis of scRNA-seq data revealed that GFER expression is significantly downregulated in intestinal epithelial cells of UC patients, suggesting a potential role in disease development. This finding is further validated in both a DSS-induced colitis mouse model and an LPS-induced in vitro inflammation model of intestinal epithelial cells, where GFER overexpression markedly inhibits the expression of ferroptosis-related markers and alleviates inflammatory damage. What's more, it is found that GFER interacts with the iron-regulating factor PCBP1 to help maintain intracellular iron homeostasis and may also reduce lipid peroxidation by activating the PGC-1α/PPARγ signaling pathway, thereby inhibiting ferroptosis. This study is the first to demonstrate the critical role of GFER in regulating ferroptosis in UC, providing new insights into the pathogenesis of UC and identifying a potential therapeutic target for future intervention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.